PHILADELPHIA & SAN FRANCISCO–(BUSINESS WIRE)–Proscia, a leading provider of artificial intelligence (AI) enabled digital pathology …
Read More »
SUMMIT, N.J., March 12, 2020 (GLOBE NEWSWIRE) — Engage Therapeutics, Inc., a clinical-stage biopharmaceutical company focused …
Read More »
Today, the U.S. Food and Drug Administration took another significant diagnostic action during the coronavirus …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
NOVI, Mich.–(BUSINESS WIRE)–Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, has announced …
Read More »
SAN FRANCISCO–(BUSINESS WIRE)–Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and …
Read More »
RIDGEFIELD, Conn., March 9, 2020 /PRNewswire/ — Boehringer Ingelheim today announced that the U.S. Food …
Read More »
OSAKA, Japan and SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) — Santen Pharmaceutical Co., Ltd. …
Read More »
LONDON–(BUSINESS WIRE)–ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. …
Read More »
HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, March 9, 2020 /PRNewswire/ — Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) …
Read More »
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb Company (NYSE: BMY) today announced topline results from ELOQUENT-1, a Phase …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission …
Read More »
The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with …
Read More »
The Phase III DANUBE trial for Imfinzi (durvalumab) and Imfinzi plus tremelimumab in unresectable, Stage IV (metastatic) bladder cancer …
Read More »
DUBLIN, March 5, 2020 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company …
Read More »
NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that …
Read More »
March 5, 2020, Boston (MA, US), Ghent (Belgium) – Orionis Biosciences is today debuting with …
Read More »
March 5, 2020—ATLANTA— The burden of colorectal cancer is swiftly shifting to younger individuals as …
Read More »
SOUTH SAN FRANCISCO, Calif., March 5, 2020 /PRNewswire/ — Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
